SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-23-037882
Filing Date
2023-11-08
Accepted
2023-11-08 16:28:18
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A aadi-20231108.htm   iXBRL 8-K/A 29401
2 EX-99.1 aadi-20231108xex9911.htm EX-99.1 103515
6 aadilogo-pressreleasea.jpg GRAPHIC 11355
  Complete submission text file 0001628280-23-037882.txt   283592

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20231108.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20231108_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20231108_pre.xml EX-101.PRE 13040
8 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20231108_htm.xml XML 2834
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38560 | Film No.: 231388317
SIC: 2834 Pharmaceutical Preparations